Abiopharma

InvenTrust Properties Corp. Declares Second Quarter 2026 Cash Dividend

NextNav Announces Redemption of 5.00% Senior Secured Convertible Notes

Results of institutional tender

Definium Therapeutics Announces New Employee Inducement Grants

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026

CVB Financial Corp. Announces Authorization of 15 Million Share Repurchase Plan

Verastem Oncology to Host Investor Conference Call and Report Updated Data and Progress Across VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor TARGET-D Clinical Program

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares